JPMorgan Starts ZIOPHARM Oncology (ZIOP) at Overweight
Tweet Send to a FriendGet Alerts ZIOP Hot Sheet
Price: $1.94 -0.51%
Rating Summary:
4 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
4 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade ZIOP Now!
JPMorgan initiates coverage on ZIOPHARM Oncology (NASDAQ: ZIOP) with an Overweight. PT $7.00.
For an analyst ratings summary and ratings history on ZIOPHARM Oncology click here. For more ratings news on ZIOPHARM Oncology click here.
Shares of ZIOPHARM Oncology closed at $4.39 yesterday, with a 52 week range of $3.55-$7.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ZIOPHARM Oncology click here. For more ratings news on ZIOPHARM Oncology click here.
Shares of ZIOPHARM Oncology closed at $4.39 yesterday, with a 52 week range of $3.55-$7.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
- Wells Fargo Starts StealthGas (GASS) at Outperform
- Wedbush Starts Intuitive Surgical (ISRG) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
